Insider activities archive   |   Recent insider buys   |   Top 10 insider buys   |   Privacy



Stock Trading History of Liepmann Holger A

The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Liepmann Holger A since year 2005. The trader's CIK number is 1283517. At the time of this reporting, Liepmann Holger A is the Executive Vice President of Abbott Laboratories . (stock ticker symbol ABT). See this page for all insider trading activities at Abbott Laboratories .

Stock purchases, sales, and option exercises reported by insider Liepmann Holger A since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2008-02-19 ABT Abbott Laboratories Sale 884 56.00 49,500
2007-12-27 ABT Abbott Laboratories Sale 8,977 57.58 516,850
2007-12-27 ABT Abbott Laboratories Option Exercise 8,977 47.99 430,819
2007-12-07 ABT Abbott Laboratories Option Exercise 4,654 43.24 201,240
2007-03-09 ABT Abbott Laboratories Option Exercise 51,924 41.56 2,157,825
2007-02-15 ABT Abbott Laboratories Sale 1,800 52.81 95,059
2007-01-29 ABT Abbott Laboratories Option Exercise 8,298 46.59 386,608
2007-01-29 ABT Abbott Laboratories Sale 8,298 52.57 436,225
2006-06-30 ABT Abbott Laboratories Option Exercise 20,459 33.23 679,881
2006-02-21 ABT Abbott Laboratories Sale 310 43.86 13,596
2006-02-15 ABT Abbott Laboratories Option Exercise 2,875 34.77 99,971
2006-01-31 ABT Abbott Laboratories Option Exercise 23,344 37.08 865,595
2006-01-31 ABT Abbott Laboratories Sale 2,063 42.73 88,151

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Liepmann Holger A (Executive Vice President of Abbott Laboratories at the time of this reporting) see the Securities and Exchange Commission (SEC) website.

© 2005-2008, insider-monitor.com. All rights reserved.